Cullinan Therapeutics, Inc.
CGEMNasdaqCIK 1789972HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | 33.8Research and development, Q3 FY2023, three months to 2023-09-30$33.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | 34.8Research and development, Q4 FY2023, three months to 2023-12-31$34.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-27, accession 0000950170-25-028346. Derived: 12-month figure less the 9-month figure.Report this figure | 30.6Research and development, Q1 FY2024, three months to 2024-03-31$30.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | 36.3Research and development, Q2 FY2024, three months to 2024-06-30$36.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104551.Report this figure | 35.5Research and development, Q3 FY2024, three months to 2024-09-30$35.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | 40.5Research and development, Q4 FY2024, three months to 2024-12-31$40.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099362. Derived: 12-month figure less the 9-month figure.Report this figure | 41.5Research and development, Q1 FY2025, three months to 2025-03-31$41.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | 61.0Research and development, Q2 FY2025, three months to 2025-06-30$61.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure | 42.0Research and development, Q3 FY2025, three months to 2025-09-30$42.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | 42.9Research and development, Q4 FY2025, three months to 2025-12-31$42.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099362. Derived: 12-month figure less the 9-month figure.Report this figure | 42.1Research and development, Q1 FY2026, three months to 2026-03-31$42.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | 44.4Research and development, Q2 FY2026, three months to 2026-06-30$44.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure |
| Operating income | $m | (45.2)Operating income, Q3 FY2023, three months to 2023-09-30−$45.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | (45.5)Operating income, Q4 FY2023, three months to 2023-12-31−$45.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0000950170-25-028346. Derived: 12-month figure less the 9-month figure.Report this figure | (43.0)Operating income, Q1 FY2024, three months to 2024-03-31−$43.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | (50.0)Operating income, Q2 FY2024, three months to 2024-06-30−$50.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104551.Report this figure | (48.9)Operating income, Q3 FY2024, three months to 2024-09-30−$48.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | (55.0)Operating income, Q4 FY2024, three months to 2024-12-31−$55.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099362. Derived: 12-month figure less the 9-month figure.Report this figure | (55.0)Operating income, Q1 FY2025, three months to 2025-03-31−$55.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | (75.8)Operating income, Q2 FY2025, three months to 2025-06-30−$75.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure | (55.6)Operating income, Q3 FY2025, three months to 2025-09-30−$55.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | (55.3)Operating income, Q4 FY2025, three months to 2025-12-31−$55.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099362. Derived: 12-month figure less the 9-month figure.Report this figure | (53.7)Operating income, Q1 FY2026, three months to 2026-03-31−$53.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | (57.3)Operating income, Q2 FY2026, three months to 2026-06-30−$57.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure |
| Income tax | $m | 0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-08, accession 0000950170-23-060679.Report this figure | (14.1)Income tax, Q4 FY2023, three months to 2023-12-31−$14.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-02-27, accession 0000950170-25-028346. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | (39.2)Net income, Q3 FY2023, three months to 2023-09-30−$39.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | (23.8)Net income, Q4 FY2023, three months to 2023-12-31−$23.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0000950170-25-028346. Derived: 12-month figure less the 9-month figure.Report this figure | (37.1)Net income, Q1 FY2024, three months to 2024-03-31−$37.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | (42.0)Net income, Q2 FY2024, three months to 2024-06-30−$42.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104551.Report this figure | (40.6)Net income, Q3 FY2024, three months to 2024-09-30−$40.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | (47.6)Net income, Q4 FY2024, three months to 2024-12-31−$47.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099362. Derived: 12-month figure less the 9-month figure.Report this figure | (48.5)Net income, Q1 FY2025, three months to 2025-03-31−$48.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | (70.1)Net income, Q2 FY2025, three months to 2025-06-30−$70.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104551.Report this figure | (50.6)Net income, Q3 FY2025, three months to 2025-09-30−$50.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | (50.7)Net income, Q4 FY2025, three months to 2025-12-31−$50.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099362. Derived: 12-month figure less the 9-month figure.Report this figure | (49.7)Net income, Q1 FY2026, three months to 2026-03-31−$49.7m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure | (53.7)Net income, Q2 FY2026, three months to 2026-06-30−$53.7m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure |
| Diluted EPS | $ per share | (0.91)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | not reported | (0.86)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-05-15, accession 0000950170-24-060535.Report this figure | (0.75)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-08-08, accession 0000950170-24-093320.Report this figure | (0.69)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | (0.91)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | not reported | (0.86)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-05-15, accession 0000950170-24-060535.Report this figure | (0.75)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-08-08, accession 0000950170-24-093320.Report this figure | (0.69)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.69 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 64.8Cash and equivalents, Q3 FY2023, at 2023-09-30$64.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0000950170-23-060679.Report this figure | 98.4Cash and equivalents, FY2023, at 2023-12-31$98.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0000950170-25-028346.Report this figure | 74.2Cash and equivalents, Q1 FY2024, at 2024-03-31$74.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0000950170-24-060535.Report this figure | 115Cash and equivalents, Q2 FY2024, at 2024-06-30$115.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093320.Report this figure | 102Cash and equivalents, Q3 FY2024, at 2024-09-30$102.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | 83.0Cash and equivalents, FY2024, at 2024-12-31$83.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001193125-26-099362.Report this figure | 76.7Cash and equivalents, Q1 FY2025, at 2025-03-31$76.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | 72.8Cash and equivalents, Q2 FY2025, at 2025-06-30$72.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104551.Report this figure | 103Cash and equivalents, Q3 FY2025, at 2025-09-30$103.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | 88.3Cash and equivalents, FY2025, at 2025-12-31$88.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure | 75.1Cash and equivalents, Q1 FY2026, at 2026-03-31$75.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | 78.6Cash and equivalents, Q2 FY2026, at 2026-06-30$78.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure |
| Current assets | $m | 477Current assets, Q3 FY2023, at 2023-09-30$476.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-060679.Report this figure | 480Current assets, FY2023, at 2023-12-31$480.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000950170-25-028346.Report this figure | 446Current assets, Q1 FY2024, at 2024-03-31$445.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060535.Report this figure | 678Current assets, Q2 FY2024, at 2024-06-30$677.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093320.Report this figure | 592Current assets, Q3 FY2024, at 2024-09-30$592.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | 415Current assets, FY2024, at 2024-12-31$414.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099362.Report this figure | 318Current assets, Q1 FY2025, at 2025-03-31$317.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | 276Current assets, Q2 FY2025, at 2025-06-30$275.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104551.Report this figure | 342Current assets, Q3 FY2025, at 2025-09-30$342.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | 387Current assets, FY2025, at 2025-12-31$386.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure | 361Current assets, Q1 FY2026, at 2026-03-31$361.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | 342Current assets, Q2 FY2026, at 2026-06-30$342.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure |
| Total assets | $m | 495Total assets, Q3 FY2023, at 2023-09-30$494.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-060679.Report this figure | 484Total assets, FY2023, at 2023-12-31$484.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000950170-25-028346.Report this figure | 449Total assets, Q1 FY2024, at 2024-03-31$449.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0000950170-24-060535.Report this figure | 681Total assets, Q2 FY2024, at 2024-06-30$681.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093320.Report this figure | 653Total assets, Q3 FY2024, at 2024-09-30$653.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | 622Total assets, FY2024, at 2024-12-31$621.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-10, accession 0001193125-26-099362.Report this figure | 580Total assets, Q1 FY2025, at 2025-03-31$579.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | 520Total assets, Q2 FY2025, at 2025-06-30$520.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104551.Report this figure | 484Total assets, Q3 FY2025, at 2025-09-30$484.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | 448Total assets, FY2025, at 2025-12-31$448.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure | 403Total assets, Q1 FY2026, at 2026-03-31$403.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | 364Total assets, Q2 FY2026, at 2026-06-30$363.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure |
| Current liabilities | $m | 23.4Current liabilities, Q3 FY2023, at 2023-09-30$23.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-060679.Report this figure | 28.1Current liabilities, FY2023, at 2023-12-31$28.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000950170-25-028346.Report this figure | 21.9Current liabilities, Q1 FY2024, at 2024-03-31$21.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060535.Report this figure | 23.5Current liabilities, Q2 FY2024, at 2024-06-30$23.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093320.Report this figure | 24.2Current liabilities, Q3 FY2024, at 2024-09-30$24.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | 30.6Current liabilities, FY2024, at 2024-12-31$30.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099362.Report this figure | 27.3Current liabilities, Q1 FY2025, at 2025-03-31$27.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | 28.1Current liabilities, Q2 FY2025, at 2025-06-30$28.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104551.Report this figure | 32.8Current liabilities, Q3 FY2025, at 2025-09-30$32.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | 37.7Current liabilities, FY2025, at 2025-12-31$37.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure | 35.2Current liabilities, Q1 FY2026, at 2026-03-31$35.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | 40.6Current liabilities, Q2 FY2026, at 2026-06-30$40.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure |
| Total liabilities | $m | 25.9Total liabilities, Q3 FY2023, at 2023-09-30$25.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-060679.Report this figure | 30.3Total liabilities, FY2023, at 2023-12-31$30.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0000950170-25-028346.Report this figure | 23.8Total liabilities, Q1 FY2024, at 2024-03-31$23.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0000950170-24-060535.Report this figure | 25.0Total liabilities, Q2 FY2024, at 2024-06-30$25.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093320.Report this figure | 25.4Total liabilities, Q3 FY2024, at 2024-09-30$25.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | 31.5Total liabilities, FY2024, at 2024-12-31$31.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-10, accession 0001193125-26-099362.Report this figure | 27.8Total liabilities, Q1 FY2025, at 2025-03-31$27.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | 28.2Total liabilities, Q2 FY2025, at 2025-06-30$28.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104551.Report this figure | 32.8Total liabilities, Q3 FY2025, at 2025-09-30$32.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | 39.6Total liabilities, FY2025, at 2025-12-31$39.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure | 36.8Total liabilities, Q1 FY2026, at 2026-03-31$36.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | 42.0Total liabilities, Q2 FY2026, at 2026-06-30$42.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure |
| Shareholders' equity | $m | 469Shareholders' equity, Q3 FY2023, at 2023-09-30$468.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-08, accession 0000950170-23-060679.Report this figure | 454Shareholders' equity, FY2023, at 2023-12-31$453.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-27, accession 0000950170-25-028346.Report this figure | 426Shareholders' equity, Q1 FY2024, at 2024-03-31$425.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-15, accession 0000950170-24-060535.Report this figure | 656Shareholders' equity, Q2 FY2024, at 2024-06-30$656.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-08, accession 0000950170-24-093320.Report this figure | 628Shareholders' equity, Q3 FY2024, at 2024-09-30$627.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-122795.Report this figure | 590Shareholders' equity, FY2024, at 2024-12-31$590.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001193125-26-099362.Report this figure | 552Shareholders' equity, Q1 FY2025, at 2025-03-31$551.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | 492Shareholders' equity, Q2 FY2025, at 2025-06-30$492.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0000950170-25-104551.Report this figure | 451Shareholders' equity, Q3 FY2025, at 2025-09-30$451.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268066.Report this figure | 409Shareholders' equity, FY2025, at 2025-12-31$408.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001193125-26-099362.Report this figure | 366Shareholders' equity, Q1 FY2026, at 2026-03-31$366.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure | 322Shareholders' equity, Q2 FY2026, at 2026-06-30$321.8m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-06, accession 0001193125-26-336717.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $m | (34.1)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$34.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-122795. Derived: 9-month figure less the 6-month figure.Report this figure | (18.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$18.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-27, accession 0000950170-25-028346. Derived: 12-month figure less the 9-month figure.Report this figure | (38.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$38.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066384.Report this figure | (36.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$36.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104551. Derived: 6-month figure less the 3-month figure.Report this figure | (34.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$34.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268066. Derived: 9-month figure less the 6-month figure.Report this figure | (36.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$36.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099362. Derived: 12-month figure less the 9-month figure.Report this figure | (43.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$43.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | (57.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$57.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336717. Derived: 6-month figure less the 3-month figure.Report this figure | (36.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$36.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268066. Derived: 9-month figure less the 6-month figure.Report this figure | (38.1)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$38.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099362. Derived: 12-month figure less the 9-month figure.Report this figure | (46.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$46.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210304.Report this figure | (38.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$38.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336717. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $m | 0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-122795. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-27, accession 0000950170-25-028346. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-15, accession 0000950170-24-060535.Report this figure | 0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-08-08, accession 0000950170-24-093320. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268066. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001193125-26-099362. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | 0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001193125-26-099362. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
Shares
| Line item | Unit | Q2 FY20212021-06-30 | Q3 FY20212021-09-30 | Q1 FY20222022-03-31 | Q2 FY20222022-06-30 | Q3 FY20222022-09-30 | Q1 FY20232023-03-31 | Q2 FY20232023-06-30 | Q3 FY20232023-09-30 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 43.3 | 43.4 | 44.4 | 46.4 | 45.6 | 40.7 | 40.0 | 42.7 | 43.0 | 55.1 | 58.3 |
Shares outstanding: 64.35m at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.